Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Arch Ital Urol Androl [Internet]. 2024 Oct. 29 [cited 2026 Apr. 17];96(4). Available from: https://www.pagepressjournals.org/aiua/article/view/12833